GMM:NASDAQGlobal Mofy AI Limited Analysis
Data as of 2026-06-02 - not real-time
$0.14
Latest Price
8/10Risk
Risk Level: High
Executive Summary
Global Mofy AI (GMM) is trading at $0.137, barely above the computed support level of $0.12 and far below its 30‑day DCF fair value of $8.97, implying a massive price discount. Technical indicators confirm a deep bearish bias: the 20‑day SMA (0.96) sits well under both the 50‑day (1.21) and 200‑day (1.52) averages, the 14‑day RSI is at 21.9 (oversold), and the MACD line remains below its signal, all pointing to continued downside momentum. Yet volatility is extreme at 406% over 30 days, and beta is low (0.13), suggesting price swings are driven more by company‑specific risk than market movements. Fundamentals show a 36% revenue growth year‑over‑year with a respectable 40% gross margin, but operating margins are thin (4.5%) and the company posts a -34% profit margin, negative free cash flow of $‑11.4 M, and a high debt‑to‑equity ratio of 5.96, highlighting cash‑flow pressure. The balance sheet is strained, with debt ($3.69 M) exceeding cash ($1.21 M), and the ROE is –35.9%, underscoring equity erosion. Recent material news – Eaglepoint AI’s inclusion in NVIDIA’s Inception Program and an $8 M capital raise – provide a strategic boost to its AI infrastructure capabilities and funding runway, but these upside catalysts must contend with the severe max drawdown of –95% and the lack of dividend or analyst coverage.
Given the juxtaposition of a deeply discounted valuation, strong top‑line growth, and significant execution risks, the stock sits at a crossroads: short‑term price pressure is likely to persist, while medium‑ to long‑term upside hinges on the successful monetization of its AI platform and improvement of cash‑flow dynamics.
Given the juxtaposition of a deeply discounted valuation, strong top‑line growth, and significant execution risks, the stock sits at a crossroads: short‑term price pressure is likely to persist, while medium‑ to long‑term upside hinges on the successful monetization of its AI platform and improvement of cash‑flow dynamics.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 6/10
Key Factors
- Price near support with bearish SMA hierarchy
- Negative profit margin and free cash flow
- Extreme 30‑day volatility
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- 36% revenue growth and strong gross margin
- NVIDIA Inception Program participation enhancing AI credibility
- Undervalued DCF fair value versus current price
Long Term
> 3 yearsPositive
Model confidence: 5/10
Key Factors
- Strategic AI platform with potential for scalable licensing
- Continued funding opportunities and partnership pipeline
- Long‑term upside if cash‑flow turns positive and debt is reduced
Key Metrics & Analysis
Financial Health
Revenue Growth36.20%
Profit Margin-34.51%
ROE-35.92%
ROA2.74%
Debt/Equity5.96
P/B Ratio0.1
Op. Cash Flow$22.1M
Free Cash Flow$-11360446
Industry P/E42.9
Technical Analysis
TrendBearish
RSI21.9
Support$0.12
Resistance$1.64
MA 20$0.96
MA 50$1.21
MA 200$1.52
MACDBearish
VolumeIncreasing
Fear & Greed Index92.41
Valuation
Fair Value$8.97
GradeUndervalued
TypeGrowth
Risk Assessment
Beta0.13
Volatility406.85%
Sector RiskHigh
Reg. RiskHigh
Geo RiskHigh
Currency RiskMedium
Liquidity RiskHigh
Similar Tickers
ZIONP
Zions Bancorporation N.A. - Depositary Shares each representing a 1/40th ownership interest in a share of Series A Floating-Rate Non-Cumulative Perpetual Prefer
STOCKWENN
Wen Acquisition Corp
STOCKCOIN
Coinbase Global, Inc.
STOCKTTRX
Turn Therapeutics Inc.
STOCKQNTM
Quantum Biopharma Ltd.
STOCKPSFE
Paysafe Limited
STOCKThis analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.